Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you plot the chart against news (mostly positive with the exception of financing deals) over the last 2 years, it should move the pps down. Go figure.
Not tested in humans yet so it's probably 18 months or more before Ph 1 results come in.
Jazz,
In your opinion, how do the results compare to Avastin or Erbutex?
TIA
Let's see. You've got a delisting battle in 50 days and within that 50 days you can get 10 million shares of buying pressure to keep the stock above a $1.00 for ten days. Are you talking about the same mgmt team that got kicked out of the Russell three years ago by $400,000 because they did a small pipe with their insider friends just before the russell date. After that major blunder, things got progressively worse for PPHM because they had to raise more funds as institutions sold out.
Why PR it Sat morning? Were there restrictions from ASCO on timing? This PR and perhaps another could have pushed us into the Russell? Does mgmt want the push or are they trying to help someone acquire cheap shares? Will this PR be repeated Monday or will it go unnoticed by the markets?
My big concern is a half-hearted attempt by mgmt to avoid delisting (like the DIOS PR) and then delisting with cheap shares going to someone. Mgmt needs to know this will be unacceptable. I'd rather force a sale than delisting. IMO, mgmt has zero regard for the retail shareholder, even though the retail shareholder has kept them afloat for so long. I hope I'm wrong and I would love to be proven wrong. I'm not a basher, just a frustrated shareholder.
BOT's Here's what I hear from 5/17/07.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=19703065
Check his/her other "Here's what I hear" and get a laugh.
BOT, please change it to "Here's what I want you to tell the fools" or "Here's what I just made up".
I'm plugging for a sale of the company rather than delisting. I'm very tired of "we're in talks". We've been hearing for YEARS how mgmt plans to creat value. Where is the value? If AVID is worth $30 mil, then tell me BAVI and Cotara are worth $70 mil combined? I want the share price to reflect the value of the company. That's all. If mgmt can't do it, get some one that can.
Looks like they don't have the goods for Russell. The India PH 2's were approved in late Jan after a several month delay. We were told they would start soon and enrollment would go quickly. No start yet and companies burning cash. Where is the Duke paper? Where is Cotara update? Getting tired of delays. Are we being fed a bunch of BS on how important the Duke paper is? Meanwhile important technology is sitting on the bench. If things don't happen soon, we need to get the technology into more capable hands.
I looked at KOSN's pipeline. IMO not nearly as broad of potential as Bavi, Cotara and they don't have an AVID. Deal with BMS is for $230 mil and they have $70 mil in cash. Jazz, perhaps you shed some light on this.
OT - Looking at the KOSN chart, news history, short history, float and institutional interest, looks to me this thing was shorted starting last July. No real earth shattering negative news. IMO, someone was smacking this thing down. I wonder when the dance with the acquirer started?
If it is Monday it would only confirm mgmt's ineptness. Just like missing the russell three years ago by $400,000 for a small pipe. BTW, that started a severe downward trend tied to many more pipes. Time for a change (in mgmt).
It appears mgmt doesn't want the russell buying power to help with the delisting problem. If they did we would be seeing some good pr's this week. Why? Do they not have the goods or is there another reason?
You're missing a third option. Hold mgmt accountable to either deliver or sell the company to someone who can. At this stage of the game UTSW provides the tech, mgmt provides the finances and expertise to monetize the tech. UTSW is performing, mgmt has not (to date). Valuable players (ie great technology) are sitting on the bench in a world where competitors that have resources can beat us to the goal line.
I have several concerns. 1) Mgmt has not bought any shares and they really don't own much relative to float. 2) The very things that mgmt said would drive value get delayed and delayed while cash is being burned - like India ph 2 and the Duke publication. 3) The financing issues -can a deal for AVID actually get done in this credit crisis? I'm hearing getting financing is tight right now.
If mgmt actually has the goods and wants to get the stock above a $1.00 for ten days, riding the Russell buying wave (probably 8 to 10 mil shares in June) would certainly help. Do they have the goods? Do they have the savvy? Do they really want the delisting issue to go away? Whose side are they really on? Current shareholders or a future partner? Is the IB really working for us or against us? Accountability issues are brewing.
For the last two years or so, someone or some entity or a group have controlled the price. They seem to be in the "know" and have been connected to financing. IMO, the bougus pr for the russell last year was a charade and IMO mgmt knows it. My guess is accumulation by way of hedge funds or other offshore players. SEC rules don't matter cause the SEC is out of commission.
KT,
Do you think they have the goods to get in the Russell? My guess is they need a couple of press releases with real meat spread out over several days, one of which addresses future funding issues. I was expecting to see something today.
I'm a little concerned. If they had the goods, we would be seeing better volume and better price. What are you hearing BOT? If everything is so rosy, why do we see just the thorns?
With small biotechs, percentage gains really don't matter. I think market cap gains relative to earth shattering news ie efficacy are what count, particularly when compared to peer groups such as REGN, OSIP IMCL etc. Albeit some of those have products with sales. PPHM has a market cap just north of $100 mil. REGN has $1.5 bil and a pipeline.
If they have any pr's worth anything, next week is the week to start the push. The russell date is next Friday. I'm assuming mgmt wants to get back into the russell because that will create the buying pressure to get the nasdaq delisting issue resolved. If they don't parade the pony next week, they either don't have anything to parade or they don't want the delisting issue to go away.
Does mgmt benefit by delisting? Possibly if they've struck a deal where a potential buyer gets more cheap shares which delisting gives them. I'm hoping mgmt looks out for existing shareholders. I also want mgmt to know most shareholders are fed up and would try to force a sale of the company if delisting occurs.
Perhaps bavi would work on the Tustinian Devil, aka management. PPHMLOVER, we all share the pain of missed goals, delays, canceled gov contracts. This has been the most frustrating company I've ever invested in over twenty years. So much potential yet so many roadblocks. I think there is hope in the next couple of months. Either mgmt produces or I have a suspicion mgmt will be forced to sell rather than go the reverse split avenue. There are too many frustrated shareholders and mgmt doesn't own many shares.
Russell rebalance forecasts. They estimate the cutoff at $171 mil but Russell has a $1.00 min pps. This nasdaq delisting issue sure carries a lot of baggage.
http://www.itg.com/research/russ/08/index.php
BOT
When you say "I hear", are you actually hearing something or is it "Here's what I want to hear" or do you fill in the blanks or do you actually hear anything. The Duke timeline issue is a prime example. March, mid-May etc. Were you even given any time estimates? Your credibility is on the line. Also, please differentiate on what you're actually hearing. Are those just voices in your head?
If the company is targeting the timing of pr's for the russell, my guess is an expanded Ph II in GA, good Cotara news and no dilutive financing for the remaining phase II's, all this should move the pps into Russell territory which my guess is $1.08 plus or minus $.02. If our IB is really on our side, they should be able to do it. If they pull it off, there's 10 million shares of buying pressure in June. Put out a Duke paper in June and that would be like putting charcoal lighter on a flame. Let's hope they pull it off.
May 30 is the date and no trading on Memorial day, hence 9 days of trading.
Nine trading days until Russell rebalance. If mgmt can get the stock up to about $1.10 per share, there will be quite a bit of buying pressure until the final rebalance date at the end of June. That should help in the nasdaq delisting issue. A Duke paper release, expansion of the GA trial and start of the two Ph II's in India and some Cotara news should do it. A little help from R & R would help.
A demurrer is a paper most commonly filed by a defendant in response to a complaint filed by the plaintiff (a plaintiff may demur to a defendant’s answer to a complaint or the defendant's affirmative defenses, but this is uncommon). Sidenote: technically a "demurrer" is NOT a motion. One does not file a motion for demurrer nor move to demur. Despite this, most lawyers erroneously refer to a demurrer as a motion. A demurrer is typically filed at the beginning of a case, before anything else happens in a case. This is because the challenge is attacking the complaint, the paper first filed in a case to get the lawsuit started.
In lay terms, if a judge sustains a demurrer, he or she is saying so what to the causes of action or claims alleged in a complaint. In other words, the judge is saying I have read your complaint, but I don't see a valid claim or claims. If the defendant "wins" the demurrer, it will not have to file an answer to the complaint.
In legal terms, a demurrer attacks or responds to the legal sufficiency of the complaint. The demurring defendant asserts that the complaint does not amount to a legally valid claim even if the factual allegations contained in the complaint are accepted as true. Usually, a demurrer attacks a complaint as missing one or more required elements of a claim. For example, a negligence cause of action in a complaint should allege that: 1) the defendant owed a duty to the plaintiff; 2) the defendant breached the duty; 3) the breach caused plaintiff injury; and 4) the plaintiff suffered damage. A defendant could demur by saying that the complaint failed to plead one or more of these essential elements.
Besides policing poorly written or technically deficient complaints, demurrers may move to dismiss the entire complaint or individual claims in which the stated causes of action are not supported or recognized by law. For example, a complaint for breach of a promise to marry could be met by a demurrer because the law in most jurisdictions expressly prohibits such claims on public policy grounds.
Demurrers are decided by the judge rather than the jury. The judge either grants the demurrer by sustaining it, or denies it by overruling the demurrer. In ruling on a demurrer, the judge is required to accept as true all facts written in a complaint. The judge rules on whether the facts stated or alleged in the complaint, assumed to be true, constitute a cause of action [or claim] warranting continued litigation.
The demurrer motion can be made by the defendant in most U.S. state court systems. For example, demurrers are still used in California and Virginia state court civil practice.
What is BMGF?
Jazz,
What are the expectations of bavi with docetaxel? Didn't the other two chemo treatments have better results?
And the two most important trials are on the sidelines waiting to start. Meanwhile the company burns thru cash.
Both Zimmer and Vision are involved in PIPEs. So I wonder what's going on behind the curtain.
Vision Cap selling is not a good sign. It's a small fund($13 mil) and they lost money investing in PPHM. If I can recall their basis was just under a buck so they took a big hit on PPHM. Given the position they had, wonder if the had access to PPHM mgmt.
Zimmer Lucas did a $5.7 mil PIPE with PPHM in 2001. They owned about 4 mil shares less than a year ago and sold out. A friend in the hedge fund business knows them and said they're smart investors. Wonder what's up with them.
Hey Bot. It's mid-May. Where's the beef?
Where's the Duke PR? Approaching Mid May. Where's the beef?
As of now, both SP and realist are on ignore. SP has become a waste of time. No difference in posts; both useless.
There is an unlimited supply of sell when you can short, even naked short. The SEC is on the sidelines looking the other way.
I don't think mgmt really is up to speed or has the skill sets from a financial mgmt side. PL is exhibit A. They have relied on ES for the most part, and have not worked the investor crowd ie high net worth indviduals or funds. If the story is that compelling, it would not take that many supporters to keep the price stable. They fumbled several times with pipes and the russell timing, which were very big rookie mistakes. They have relied on their IB with wysiwyg results. The IB is out for themselves, not PPHM. I have heard this several times from a retired IB that focused on biotech and stays in touch with leading biotech players.
He probably has smart lawyers that know PPHM is somewhat cash strapped. His ideal settlement window IMO is before PPHM gets additional cash from a partnership agreement or Avid sale and where news of a settlement could actually help PPHM. Once PPHM doesn't need to settle, it could be a problem for Epstein.
Have you ever been in a lawsuit? If you have, you would not be asking that question. The real winners in any lawsuit are the lawyers. When you bill by the hour at anywhere from $150 to $500 per hour or more, expect things to drag on and on. Even from your own lawyer.
When I wrote "sitting on news", I meant a planned release of hopefully meaning full PR's before the russell 3000 reconstitution date which is May 30. Last year the cutoff was $261 mil. As of today the number would be about $250 mil or about $1.10 per share for PPHM. If the Duke paper lives up to billing; a release of Cotara news and phase II news, than we could get there. There will be plenty of opposition from those not prepared. Hopefully the IB would work in our favor this time.
My guess is they're sitting on news, the Duke paper, ph 2 prelim, Cotara etc for this very reason. If they can pull this off, there could be another 10 million share buy in. I think this will be tough cause they're some folks don't want it and don't play by the rules. They don't have to worry about the rules because the cops are looking the other way.